Published in Life Sci on April 19, 1982
Vagal afferent control of opioidergic effects in rat brainstem circuits. J Physiol (2006) 1.17
Opioid peptides inhibit excitatory but not inhibitory synaptic transmission in the rat dorsal motor nucleus of the vagus. J Neurosci (2002) 1.15
Inhibition of nociceptive responses after systemic administration of amidated kyotorphin. Br J Pharmacol (2011) 0.81
Effect of the endogenous analgesic dipeptide, kyotorphin, on transmitter release in sympathetic ganglia. Br J Pharmacol (1985) 0.77
Pharmacological Potential of the Endogenous Dipeptide Kyotorphin and Selected Derivatives. Front Pharmacol (2017) 0.75
Intracellular localization of liver sugar nucleotide glycoprotein glycosyltransferases in a Golgi-rich fraction. J Biol Chem (1970) 4.74
The isolation and properties of a rabbit liver binding protein specific for asialoglycoproteins. J Biol Chem (1974) 4.57
The Distress and Risk Assessment Method. A simple patient classification to identify distress and evaluate the risk of poor outcome. Spine (Phila Pa 1976) (1992) 2.16
Surgery for lumbar spinal stenosis in old people. J Bone Joint Surg Br (1993) 1.87
Genital infections with Chlamydia trachomatis in women attending an antenatal clinic. Br J Obstet Gynaecol (1984) 1.17
Enkephalinase: selective peptide inhibitors. Life Sci (1981) 1.12
Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor. J Pharmacol Exp Ther (1997) 1.11
A membrane receptor protein for asialoglycoproteins. Methods Enzymol (1974) 1.11
Positive allosteric modulators of the GABA(A) receptor: differential interaction of benzodiazepines and neuroactive steroids with ethanol. Psychopharmacology (Berl) (1999) 1.07
Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res (1993) 1.07
Porcine sugar nucleotide: glycoprotein glycosyltransferases. I. Blood serum and liver sialyltransferase. Can J Biochem (1971) 1.05
The use of the pain drawing as a screening measure to predict psychological distress in chronic low back pain. Spine (Phila Pa 1976) (1995) 1.04
Multiple opiate receptors: differential binding of mu, kappa and delta agonists. Neuropharmacology (1981) 1.04
Porcine sugar nucleotide: glycoprotein glycosyltransferases. II. Blood serum and liver galactosyltransferase. Can J Biochem (1971) 1.03
Comparative biological activities of synthetic leukotriene B4 and its omega-oxidation products. Prostaglandins (1983) 0.96
Anxiolytic and anticonvulsant activity of a synthetic neuroactive steroid Co 3-0593. Psychopharmacology (Berl) (1997) 0.96
Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo. Neuropharmacology (1991) 0.95
Reinforcing and discriminative stimulus effects of the neuroactive steroids pregnanolone and Co 8-7071 in rhesus monkeys. Psychopharmacology (Berl) (1999) 0.94
Increased rate of rapid axonal transport in vitamin E deficient rats. Brain Res (1975) 0.94
Multiple opiate receptors: support for unique mu, delta and kappa sites. Neuropharmacology (1982) 0.92
Porcine sugar nucleotide: glycoprotein glycosyltransferases. 3. Blood serum and liver N-acetylglucosaminyltransferase. Can J Biochem (1971) 0.92
Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat. J Pharmacol Exp Ther (1986) 0.92
Evidence for two CMP-N-acetylneuraminic acid: lactose sialyltransferases in rat, porcine, bovine, and human liver. Can J Biochem (1972) 0.91
Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line. Glia (1996) 0.91
Effect of ketotifen treatment on cold-induced urticaria. Ann Allergy (1985) 0.90
Changes of hippocampal Met-enkephalin content after recurrent motor seizures. Nature (1980) 0.89
The levels of nucleotide-sugar: glycoprotein sialyl- and N-acetylglucosaminyltransferases in normal and pathological human sera. Can J Biochem (1972) 0.89
Occurrence of UDP-N-acetylglucosamine: glycoprotein N-acetylglucosaminyltransferase activity in human and rat sera. Can J Biochem (1971) 0.88
Changing patterns of hearing-aid use and level of support. Br J Audiol (1984) 0.87
Spinal analgesia: comparison of the mu agonist morphine and the kappa agonist ethylketazocine. Life Sci (1981) 0.87
Sigma receptors modulate the hypothalamic-pituitary-adrenal (HPA) axis centrally: evidence for a functional interaction with NMDA receptors, in vivo. Neuropharmacology (1990) 0.87
Reduced lumbar CSF somatostatin levels in Alzheimer's disease. Life Sci (1982) 0.87
Benzodiazepine interactions with central thyroid-releasing hormone binding sites: characterization and physiological significance. J Pharmacol Exp Ther (1986) 0.86
Synthesis and biological activity of 8a-phenyldecahydroquinolines as probes of PCP's binding conformation. A new PCP-like compound with increased in vivo potency. J Med Chem (1992) 0.86
Mu opiate isoreceptors: differentiation with kappa agonists. Life Sci (1983) 0.86
Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences. Peptides (1984) 0.86
Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides. Brain Res (1987) 0.85
The senior SHO rotation in Wales--a basis for BST training. Ann R Coll Surg Engl (1996) 0.85
Effects of kappa opiate agonists on neurochemical and neuroendocrine indices: evidence for kappa receptor subtypes. Life Sci (1986) 0.85
Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors. Brain Res (1990) 0.84
Modulation of the turnover rate of acetylcholine in rat brain by intraventricular injections of thyrotropin-releasing hormone, somatostatin, neurotensin and angiotensin II. J Neurochem (1978) 0.84
Multiple opiate receptor affinities of kappa and agonist/antagonist analgesics: in vivo assessment. J Pharmacol Exp Ther (1983) 0.84
Neurochemical characterization of dopaminergic effects of opipramol, a potent sigma receptor ligand, in vivo. Neuropharmacology (1990) 0.83
Inflammation and pain sensitivity: effects of leukotrienes D4, B4 and prostaglandin E1 in the rat paw. Prostaglandins (1983) 0.83
Actions of mu, kappa, sigma, delta and agonist/antagonist opiates on striatal dopaminergic function. J Pharmacol Exp Ther (1980) 0.83
Synthesis and biological activities of leukotriene F4 and leukotriene F4 sulfone. Prostaglandins (1982) 0.83
Dopaminergic control of the septal-hippocampal cholinergic pathway. J Pharmacol Exp Ther (1979) 0.83
High affinity [3H]ethylketazocine binding: evidence for specific kappa receptors. Neuropharmacology (1982) 0.82
Dopamine autoreceptors modulate the in vivo release of dopamine in the frontal, cingulate and entorhinal cortices. J Pharmacol Exp Ther (1987) 0.81
(+) 3-[3-hydroxyphenyl-N-(1-propyl) piperidine] selectively differentiates effects of sigma ligands on neurochemical pathways modulated by sigma receptors: evidence for subtypes, in vivo. Neuropharmacology (1991) 0.81
The use of nucleotide-sugar: glycoprotein glycosyltransferases to assess Golgi apparatus function in Morris hepatomas. Can J Biochem (1971) 0.81
Morphine and nigrostriatal function in the rat and mouse: the role of nigral and striatal opiate receptors. Neuropharmacology (1982) 0.81
Substance P: evidence for spinal mediation of some behavioural effects. Neuropharmacology (1981) 0.81
Effect of sulpiride, an atypical neuroleptic, on apomorphine-induced growth hormone secretion. Brain Res Bull (1982) 0.81
Homocysteic acid as a putative excitatory amino acid neurotransmitter: I. Postsynaptic characteristics at N-methyl-D-aspartate-type receptors on striatal cholinergic interneurons. J Neurochem (1988) 0.80
Presence of the N-methyl-D-aspartate-associated glycine receptor agonist, D-serine, in human temporal cortex: comparison of normal, Parkinson, and Alzheimer tissues. J Neurochem (1993) 0.80
Intracerebral substance P in mice: behavioral effects and narcotic agents. Brain Res (1981) 0.80
In vivo assessment of dopamine and norepinephrine release in rat neocortex: gas chromatography-mass spectrometry measurement of 3-methoxytyramine and normetanephrine. J Neurochem (1987) 0.80
The metabotropic glutamate receptor antagonist L-2-amino-3-phosphonopropionic acid inhibits phosphoserine phosphatase. Eur J Pharmacol (1996) 0.80
A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease. J Neurol Sci (1983) 0.80
Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3alpha, 21-dihydroxy-3beta-trifluoromethyl-19-nor-5beta-pregnan-20-one), a selective modulator of gamma-aminobutyric acid(A) receptors. J Pharmacol Exp Ther (2000) 0.80
Microglial cathepsin B: an immunological examination of cellular and secreted species. J Neurochem (1995) 0.80
The effects of beta-phenylethylamine on tyramine and dopamine metabolism. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.80
Benzodiazepine receptor modulation of [35S]TBPS binding to the chloride channel. Noncompetitive inhibition of classical benzodiazepines and competitive inhibition of the partial agonist, CGS 9895, by CGS 8216. Neuropharmacology (1987) 0.80
Neuropharmacological characterization of 1-aminocyclopropane-1-carboxylate and 1-aminocyclobutane-1-carboxylate, ligands of the N-methyl-D-aspartate-associated glycine receptor. Neuropharmacology (1990) 0.79
Specific mu 2 opioid isoreceptor regulation of nigrostriatal neurons: in vivo evidence with naloxonazine. Neurosci Lett (1983) 0.79
GABAergic mediation in the inhibition of hippocampal acetylcholine turnover rate elicited by delta 9-tetrahydrocannabinol. Neuropharmacology (1979) 0.79
Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat. J Pharmacol Exp Ther (1982) 0.79
The effects of muscarinic receptor blockers on the turnover rate of acetylcholine in various regions of the rat brain. Can J Physiol Pharmacol (1979) 0.79
An investigation of whether septal gamma-aminobutyrate-containing interneurons are involved in the reduction in the turnover rate of acetylcholine elicited by substance P and beta-endorphin in the hippocampus. Neuroscience (1979) 0.79
Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors. Neuropharmacology (1990) 0.79
CSF acetylcholinesterase in dementia and in sequential samples of lumbar CSF. Neurobiol Aging (1984) 0.79
Axonal transport of [3H]cholesterol derived from [3H]leucine in the sciatic nerve. FEBS Lett (1980) 0.79
Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents. Eur J Pharmacol (1992) 0.79
Lack of cholinergic deficit in the neocortex in Pick's disease. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.78
Calcium metabolism in aluminum encephalopathy. Exp Neurol (1985) 0.78
Actions of enkephalin, mu and partial agonist analgesics on acetylcholine turnover in rat brain. Neuropharmacology (1980) 0.78
Kojic amine--a novel gamma-aminobutyric acid analogue. J Med Chem (1979) 0.78
CGS 19755: a novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist with anticonvulsant, anxiolytic and anti-ischemic properties. Prog Clin Biol Res (1990) 0.78
Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists. Naunyn Schmiedebergs Arch Pharmacol (1988) 0.78
Novel phosphoserine phosphatase inhibitors. Eur J Pharmacol (1997) 0.78
A selected ion monitoring assay for dopamine and its metabolites using negative chemical ionization. Biomed Mass Spectrom (1982) 0.78
Monoamines as possible mediators in the regulation of fast axoplasmic flow. J Neurochem (1976) 0.78
Preparation and stability of low-cost liquid quality-control serum stabilized with ethanediol. Clin Chem (1987) 0.78
Opipramol, a potent sigma ligand, is an anti-ischemic agent: neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurements. Neuropharmacology (1990) 0.78
A prolactin action on acetylcholine metabolism in striatum, hippocampus, and thalamus. J Neurochem (1980) 0.78
CCD-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat. J Pharmacol Exp Ther (1997) 0.78
Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivo. Life Sci (1989) 0.78
Increased axoplasmic flow associated with pargyline under conditions which induce a myopathy. Nature (1975) 0.78
Pharmacological evaluation of GABAergic and glutamatergic inputs to the nucleus basalis--cortical and the septal-hippocampal cholinergic projections. Can J Physiol Pharmacol (1986) 0.77
Intracerebral dialysis: direct evidence for the utility of 3-MT measurements as an index of dopamine release. Life Sci (1987) 0.77
Agonist action of the agonist/antagonist analgesic butorphanol on dopamine metabolism in the nucleus accumbens of the rat. Neurosci Lett (1987) 0.77